Patient-derived GBM cells and established human GBM cell lines (U87, U51, U235) treated with 25 μM curcumin have been shown to have increased expression of phosphorylated ERK, p38 and JNK (via c-Jun) at one and six hours. This evidence concerns the gene MAPK8 and glioblastoma.